Dianicline

<h2 id="references">References</h2>

<ol>
<li id="fn:1"><p>Cohen C, Bergis OE, Galli F, Lochead AW, Jegham S, Biton B, et al. (July 2003). "SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation". The Journal of Pharmacology and Experimental Therapeutics. 306 (1): 407–20. doi:10.1124/jpet.103.049262. PMID 12682217. S2CID 37543790. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li>
<li id="fn:2"><p>Fagerström K, Balfour DJK. Neuropharmacology and potential efficacy of new treatments for tobacco dependence. Expert Opinion on Investigational Drugs. 2006; 15(2):107-116. <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li>
<li id="fn:3"><p>Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation <a href="https://clinicaltrials.gov/ct2/show/NCT00356967" target="_blank">https://clinicaltrials.gov/ct2/show/NCT00356967</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li>
<li id="fn:4"><p>"Sanofi Pipeline" (PDF). Archived from the original (PDF) on 2008-12-04. Retrieved 2009-06-24. <a href="https://web.archive.org/web/20081204130421/http://www.en.sanofi-aventis.com/binaries/080212_PDF_Slides_media_tcm28-15767.pdf" target="_blank">https://web.archive.org/web/20081204130421/http://www.en.sanofi-aventis.com/binaries/080212_PDF_Slides_media_tcm28-15767.pdf</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li>
</ol>

Dianicline open-in-new

Dianicline